Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer

Tamoxifen (TAM) has been prescribed for decades and aromatase inhibitors (AIs) have been used since the early 2000s in preventing subsequent breast cancer. However, outside of clinical trials, the effectiveness of AIs is not established. We examined the long-term risk of subsequent breast cancer amo...

Descrición completa

Detalles Bibliográficos
Autores principales: Haque, Reina, Ahmed, Syed A, Fisher, Alice, Avila, Chantal C, Shi, Jiaxiao, Guo, Amy, Craig Cheetham, T, Schottinger, Joanne E
Formato: Online Artigo Texto
Idioma:English
Publicado: WILEY-VCH Verlag 2012
Materias:
Clinical Cancer Research
Acceso en liña:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544463/
https://www.ncbi.nlm.nih.gov/pubmed/23342281
http://dx.doi.org/10.1002/cam4.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544463/
https://www.ncbi.nlm.nih.gov/pubmed/23342281
http://dx.doi.org/10.1002/cam4.37

Títulos similares